Adaire Fox-Martin - 17 Feb 2026 Form 4 Insider Report for EQUINIX INC (EQIX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
19 Feb 2026, 16:07:43 UTC
Prior SEC filing
09 Feb 2026
Next SEC filing
13 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Samantha Lagocki, POA

Key filing fact

Adaire Fox-Martin filed Form 4 for EQUINIX INC (EQIX) on 19 Feb 2026.

Key facts

  • This page summarizes Adaire Fox-Martin's Form 4 filing for EQUINIX INC (EQIX).
  • 21 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 19 Feb 2026, 16:07.

Change

  • Previous filing in this sequence was filed on 09 Feb 2026.
  • Current net transaction value: -$3,946,973.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001795624 Primary reporting owner

Fox-Martin Adaire

Relationship
CEO and President, Director
Address
C/O EQUINIX, INC., ONE LAGOON DRIVE, REDWOOD CITY
Signature
/s/ Samantha Lagocki, POA
Signature date
19 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EQIX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,669
Change %
+18%
Price
$0.000000
Shares after
17,559
Date
17 Feb 2026
Ownership
Direct
Footnotes
F1
EQIX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+5,297
Change %
+30%
Price
$0.000000
Shares after
22,856
Date
17 Feb 2026
Ownership
Direct
EQIX transaction

Common Stock

Sale

Transaction value
$93,483
Shares
-101
Change %
-0.44%
Price
$925.58
Shares after
22,755
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F3
EQIX transaction

Common Stock

Sale

Transaction value
$746,974
Shares
-806
Change %
-3.5%
Price
$926.77
Shares after
21,949
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F4
EQIX transaction

Common Stock

Sale

Transaction value
$373,719
Shares
-403
Change %
-1.8%
Price
$927.34
Shares after
21,546
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F5
EQIX transaction

Common Stock

Sale

Transaction value
$469,886
Shares
-506
Change %
-2.3%
Price
$928.63
Shares after
21,040
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F6
EQIX transaction

Common Stock

Sale

Transaction value
$161,700
Shares
-174
Change %
-0.83%
Price
$929.31
Shares after
20,866
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F7
EQIX transaction

Common Stock

Sale

Transaction value
$260,521
Shares
-280
Change %
-1.3%
Price
$930.43
Shares after
20,586
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F8
EQIX transaction

Common Stock

Sale

Transaction value
$186,417
Shares
-200
Change %
-0.97%
Price
$932.08
Shares after
20,386
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F9
EQIX transaction

Common Stock

Sale

Transaction value
$112,051
Shares
-120
Change %
-0.59%
Price
$933.76
Shares after
20,266
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F10
EQIX transaction

Common Stock

Sale

Transaction value
$112,120
Shares
-120
Change %
-0.59%
Price
$934.33
Shares after
20,146
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F11
EQIX transaction

Common Stock

Sale

Transaction value
$106,811
Shares
-114
Change %
-0.57%
Price
$936.94
Shares after
20,032
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F12
EQIX transaction

Common Stock

Sale

Transaction value
$80,726
Shares
-86
Change %
-0.43%
Price
$938.67
Shares after
19,946
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F13
EQIX transaction

Common Stock

Sale

Transaction value
$385,125
Shares
-410
Change %
-2.1%
Price
$939.33
Shares after
19,536
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F14
EQIX transaction

Common Stock

Sale

Transaction value
$141,027
Shares
-150
Change %
-0.77%
Price
$940.18
Shares after
19,386
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F15
EQIX transaction

Common Stock

Sale

Transaction value
$301,339
Shares
-320
Change %
-1.7%
Price
$941.68
Shares after
19,066
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F16
EQIX transaction

Common Stock

Sale

Transaction value
$188,555
Shares
-200
Change %
-1%
Price
$942.77
Shares after
18,866
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F17
EQIX transaction

Common Stock

Sale

Transaction value
$226,520
Shares
-240
Change %
-1.3%
Price
$943.84
Shares after
18,626
Date
18 Feb 2026
Ownership
Direct
Footnotes
F2, F18

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EQIX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-2,669
Change %
-50%
Price
$0.000000
Shares after
2,668
Date
17 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,669
Exercise price
$0.000000
Footnotes
F19, F20
EQIX transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+10,594
Change %
Price
$0.000000
Shares after
10,594
Date
17 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,594
Exercise price
$0.000000
Footnotes
F20, F21
EQIX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-5,297
Change %
-50%
Price
$0.000000
Shares after
5,297
Date
17 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,297
Exercise price
$0.000000
Footnotes
F20, F21
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 21 footnotes

Footnote F1

32.243 shares acquired under the Equinix, Inc. Employee Stock Purchase Plan on February 13, 2026.

Footnote F2

Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $925.00 to $925.95, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 through 18 to this Form 4.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $926.01 to $927.00 inclusive.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $927.04 to $928.00 inclusive.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $928.07 to $929.07 inclusive.

Footnote F7

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $929.13 to $929.55 inclusive.

Footnote F8

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $930.27 to $930.72 inclusive.

Footnote F9

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $931.85 to $932.29 inclusive.

Footnote F10

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $933.18 to $934.09 inclusive.

Footnote F11

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $934.30 to $934.44 inclusive.

Footnote F12

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $936.60 to $937.29 inclusive.

Footnote F13

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $937.82 to $938.75 inclusive.

Footnote F14

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $938.90 to $939.90 inclusive.

Footnote F15

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $940.00 to $940.51 inclusive.

Footnote F16

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $941.53 to $942.41 inclusive.

Footnote F17

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $942.60 to $942.89 inclusive.

Footnote F18

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $943.71 to $943.86 inclusive.

Footnote F19

On March 7, 2024 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2024. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2025, 25% will vest on February 15, 2026 and the remaining 25% will vest on February 15, 2027, subject solely to continued service.

Footnote F20

Restricted stock unit award expires upon reporting person's termination of service.

Footnote F21

On March 11, 2025 the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the attainment of certain AFFO, Revenue and EBITDA targets for 2025. The Compensation Committee certified the degree to which the targets were achieved, therefore 50% of the award vested on February 15, 2026, 25% will vest on February 15, 2027 and the remaining 25% will vest on February 15, 2028, subject solely to continued service.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .